Project Grant R01NS146848
- Federal Grant Award Summary The University of Pittsburgh received a $1.15 million Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded on March 15, 2025, with a completion date of January 31, 2030. The grant funds research to investigate the neuronal circuitry and central sensitization mechanisms underlying mechanical allodynia—a debilitating...
- Federal Project Grant Award Summary The University of Pittsburgh received a $239,052 Project Grant awarded on June 12, 2025, from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The research project, "Targeting Spinal Orexins to Treat Chronic Pain," will be conducted through February 29, 2028, and seeks to advance understanding of how orexinergic neurons...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Pennsylvania a Project Grant totaling $667,349 (awarded August 1, 2025, with completion targeted for June 30, 2030) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This research grant supports a neuroscience investigation into state-dependent control of nociception (pain sensation) in opioid circuits,...
- Federal Project Grant Award Summary The University of Pittsburgh received a $571,404 Project Grant awarded May 30, 2025, by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). The research project, titled "Adipokines as Novel Therapy to Promote Functional Recovery After Experimental Traumatic Brain Injury," will extend through April 30, 2030. This award funds...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The University of Pennsylvania a $446,875 Project Grant effective June 1, 2025, through May 31, 2027, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). The research project focuses on generating and characterizing a novel NTRK3-FLPO knockin mouse line to enable genetic interrogation of Aβ nociceptors—a previously inaccessible population of...
- Federal Project Grant Award Summary The University of Pittsburgh received a $9.8 million Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate biopsychosocial mechanisms underlying inter-individual differences in walking pain and functional impairment among individuals with knee osteoarthritis (OA). The award, effective September 19, 2025, with completion anticipated by August 31,...
- Federal Project Grant Award Summary Duquesne University received a $517,494 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective July 1, 2025, through June 30, 2028. The award funds research to identify differentially expressed RNA splice isoforms of the transcription factor ATF3 (Activating Transcription Factor 3) that account for sex-specific...
- Federal Project Grant Award Summary The University of Pittsburgh received a $443,354 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded May 15, 2025, with completion scheduled for April 30, 2030. This research initiative targets metabolic vulnerabilities in diffuse midline gliomas (DMG) with H3K27A mutations, pediatric brain tumors carrying a...
- Federal Project Grant Summary Massachusetts Institute of Technology received a $591,122 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025, with completion targeted for July 31, 2029. The award supports fundamental neuroscience research investigating the emotional/affective component of pain through identification and...
- Federal Project Grant Award Summary The University of Pittsburgh received a $2.35 million Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, awarded September 8, 2025, with completion expected by June 30, 2029. This research grant supports an investigator-initiated project investigating the role of the SPAK-NKCC1 (STE20-related serine-proline-alanine...
The University of Pittsburgh received a $620,504 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective February 11, 2026, with completion by November 30, 2030. This research project investigates how the brain resolves competing survival needs by examining neural circuits in the lateral parabrachial nucleus (LPBN), a brainstem region that integrates pain signals with other survival-critical information such as hunger, thirst, and fear. The research focuses on determining whether neuropeptide Y (NPY) signaling from multiple brain regions can suppress chronic pain-related neural activity and whether blocking NPY1 receptors in the LPBN prevents the pain-reducing effects of competing physiological and psychological states. The project delivers fundamental neuroscience research outcomes through experimental investigation and manipulation of neural circuits across multiple chronic pain models, including inflammatory pain, latent sensitization models, and neuropathic pain. Research activities encompass identifying neural inputs that trigger NPY release during internal need states and external threats, characterizing how this signaling reverses hyperresponsiveness of LPBN neurons to sensory stimulation, and applying Y1 receptor pharmacology to understand circuit mechanisms. These research products advance understanding of how the brain prioritizes survival behaviors and may inform development of novel chronic pain management strategies by targeting the identified neural hub mechanisms.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $620.5k | 2/10/26 |